Medicines and Healthcare products Regulatory Agency (MHRA) in the UK is supporting the pharmaceutical industry for developing user-friendly packaging for medicines prescribed for Alzheimer's patients.
The new packaging is expected to remind consumers on their medicine intake, helping them to be as independent as possible.
Alzheimer's medicines, including galantamine, rivastigmine, donepezil and memantine, will include the days of the week clearly on the blister packs.
The improved packaging is expected to be available from next June, MHRA said.
Alzheimer's Society policy head George McNamara said: "Simple modifications, such as indicating the days of the week or making the font clearer to read, can have huge implications for both the independence and the safety of people living with dementia.
"While it's encouraging to see this change being implemented for dementia medication, nearly three-quarters of people with dementia are also living with other long-term illnesses. We would like to see other companies within the pharmaceutical industry following suit to create dementia-friendly medication packaging across the board."
This new packaging modification is intended to help patients in adhering to doctor-prescribed dosages for medicines, thus maximising efficacy of treatment.
Life sciences minister George Freeman said: "Dementia is a devastating condition, which is why we are committed to ensuring that the UK becomes a world leader in care, support and research by 2020, thanks to the prime minister's challenge on dementia.
"Medicines packaging, which clearly indicates when to take each tablet, will help to give greater independence to those living with dementia, and improve confidence, safety, and outcomes."
Image: The new packaging modifications can help in maximising efficacy of dementia treatments. Photo: courtesy of UK Government.